; (B) not more than 50 percent of the grant for training manufacturing workers; and (C) not more than 25 percent of the grant for developing one or more new prescription drugs, new active pharmaceutical ingredients, or new antibiotics. (3) Source of funding All amounts used to carry out this section shall be derived from the Fund. (e) Report Not later than one year after the date of enactment of this Act, and annually thereafter, the Secretary of Health and Human Services shall submit to the Congress a report on the Fund. Each such report shall address the following: (1) The amounts deposited into the Fund in the most recent three fiscal years. (2) The distribution of such amounts pursuant to grants under this section during the last three fiscal years, including the allocation of such amounts for— (A) new or expanded manufacturing capacity; (B) training workers